© Globe Newswire
02.06.2025
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.06.2025
GXI
LISTED
XETR
Anpassung der Prognose für 2025
News Preview
Gerresheimer AG: Anpassung der Prognose für 2025
Düsseldorf, 2. Juni 2025. Die Gerresheimer AG (ISIN: DE000A0LD6E6) passt ihre Prognose für das Geschäftsjahr 2025 an. Hintergrund ist insbesondere die weiterhin anhaltende gedämpfte Nachfrage im Kosmetikmarkt sowie ein von der Gesellschaft als temporär eingeschätzter Nachfragerückgang im Bereich Con......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.06.2025
GXI
LISTED
XETR
Adjustment of Guidance for 2025
News Preview
Gerresheimer AG: Adjustment of Guidance for 2025
Duesseldorf, June 2, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) is adjusting its guidance for 2025. This is due in particular to continuing subdued demand in the cosmetics market and a decline in demand for containment solutions for oral liquid medications, which the company considers to be tempora......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
02.06.2025
NSIS B
LISTED
CPH
Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance
News Preview
Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2)....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
02.06.2025
TIL
LISTED
NASDAQ
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
News Preview
DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced the appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer. Dr. Freedman brings deep experience in oncology drug development and o...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2025
ATAI
LISTED
NASDAQ
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
News Preview
NEW YORK and BERLIN and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, and Beckley Psytech Limited (“Beckley”), a private clinical-stage bio...
Themefolio
Profiler
Peergroup
© PR Newswire
02.06.2025
INDV
LISTED
NASDAQ
Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained
News Preview
SLOUGH, England and RICHMOND, Va., June 2, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its intention to cancel: (i) the secondary listing of the Company's Ordinary Shares ("Ordinary Shares") on the Equity Shares (Transition) category of the Official List (the "Official List") of the U.K. Financial Conduct Authority ("FCA"...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2025
ZEAL
LISTED
CPH
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
News Preview
Press release – No. 10 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
01.06.2025
TEM
LISTED
NASDAQ
Introducing Tempus One in the EHR with Integrated Guidelines
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One—its generative AI clinical assistant—with direct integration into electronic health record (EHR) systems. By integrating AI at every point of the clinical care process, the expan...
Themefolio
Profiler
Peergroup
© BusinessWire
31.05.2025
ZLAB
LISTED
NASDAQ
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and simultaneously published in the Journal of Cli...
Themefolio
Profiler
Peergroup
© BusinessWire
31.05.2025
TEM
LISTED
NASDAQ
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of its Fuses program. This initiative will harness Tempus’ proprietary dataset to generate valuable insights for both patient care and research, combining the power of its data and machine learni...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2025
IBAB
LISTED
EURONEXT
Iba – Acquisition of Own Shares - Completion of the Share Buyback Program
News Preview
Immediate Release – May 30th, 2025...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
30.05.2025
COPN
LISTED
SIX
Voting Results of Cosmo's 2025 AGM
News Preview
Dublin, Ireland--(Newsfile Corp. - May 30, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting. A total of 9,135,061 ordinary shares of the share capital of Cosmo were represented at this general meeting of sha...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
BLUE
LISTED
NASDAQ
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
News Preview
Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and Beacon Parent Holdings, L.P. (“Parent”) today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) for either (x) $3.00 per share in cash and a contingent value right pe...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
TEM
LISTED
NASDAQ
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for presentation at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting. The event will take place May 30 - June 3 in Chicago, Illinois. Tempus will p...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in June 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in June 2025:
Jefferies Global Healthcare Conference
Fireside Chat: Wednesday, June 4, 2025, 10:30 a.m. EST
Webcast Link: https://wsw.com/webcast/jeff319/zlab/1845848
Location: Ne...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2025
RXRX
LISTED
NASDAQ
Recursion to Participate in Upcoming Investor Conferences
News Preview
Salt Lake City, May 30, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
News Preview
MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2025 M...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2025
TIL
LISTED
NASDAQ
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
News Preview
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 4:20PM ET on Thursday, June 5, 2025. A live w...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2025
EUZ
LISTED
XETR
Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
News Preview
BOSTON, Mass., 30 May 2025. Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, underscoring its continued leadership in the radiopharmaceutical industry. Building upon the success of the previous editions, this year's event gathered around 100 decision makers, renowned experts, key partners, and influ......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2025
EUZ
LISTED
XETR
Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum
News Preview
BOSTON, Massachusetts, 30. Mai 2025. Eckert & Ziegler hat die 3. Auflage des Boston Radionuclide Theranostics Forums erfolgreich abgeschlossen und unterstreicht damit erneut seine Führungsrolle in der radiopharmazeutischen Industrie. Aufbauend auf dem Erfolg der vorherigen Jahre, versammelte die diesjährige Veranstaltung rund 100 Entscheidungst......
Themefolio
Profiler
Peergroup
© PR Newswire
29.05.2025
CU6
LISTED
ASX
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
News Preview
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the first patient in its registrational Phase III 64Cu...
Themefolio
Profiler
Peergroup
© BusinessWire
29.05.2025
TEM
LISTED
NASDAQ
Tempus AI, Inc. (NASDAQ: TEM) Securities Fraud Investigation; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
News Preview
Shares of Tempus AI, Inc. fell over 19% in intraday trading on Wednesday, May 28, 2025, after Spruce Point Capital Management published a report alleging that Tempus AI is engaging in “aggressive and suspicious accounting practices,” and the company’s leaders are “connected to troubling financial restatements and SEC-charged fraud allegations.” Gi...
Themefolio
Profiler
Peergroup
© BusinessWire
29.05.2025
TEM
LISTED
NASDAQ
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
TEM
LISTED
NASDAQ
Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation – TEM
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations that Tempus AI may have issued materially misleading business information to the investing public.
So What: If you purchased Tempus AI securities y...
Themefolio
Profiler
Peergroup
© ActuNews
28.05.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 28 mei 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen:
Oxurion ontving een transparant...
Themefolio
Profiler
Peergroup
© ActuNews
28.05.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – May 28, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows:
Oxurion received a transparency notification on May 27, 2025, from Atlas Spe...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
TEM
LISTED
NASDAQ
A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced its participation in almost 1,500 research projects in just the last ten years. This milestone highlights Tempus’ ongoing commitment to accelerating scientific discovery and delivering data-driven insights...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
DFTX
LISTED
NASDAQ
MindMed to Participate in June Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Jefferies Global Healthcare Conferenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2025
GN
LISTED
CPH
Trading in GN Store Nord shares by board members, executives and associated persons
News Preview
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them....
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2025
SOBI
LISTED
STO
Sobi to share new clinical data and research at EULAR 2025
News Preview
STOCKHOLM, May 28, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will present new clinical data and research outcomes at the annual European Congress of Rheumatology (EULAR 2025) in Barcelona from the 11-14 June 2025. Research will include clinical trial outcomes on the efficacy and safety of Gamifant in the treatment of macrophage activating syndrome,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2025
SECT_B
LISTED
STO
Sectra equips multi-site US health system with enterprise imaging as a cloud service and accelerates AI adoption for improved patient diagnostics
News Preview
LINKÖPING, Sweden, May 28, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide a US health system with its enterprise imaging solution as a cloud service, Sectra One Cloud, including its AI service, Sectra Amplifier Service. The fully managed cloud service will strengthen the health sy...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2025
ANAB
LISTED
NASDAQ
Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
News Preview
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global Phase 2b RENOIR clinical trial of investigational rosnilimab, a depleter and agonist target...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2025
ILM1
LISTED
XETR
Aktionäre stimmen sämtlichen Beschlussvorschlägen zu
News Preview
Pressemitteilung
Hauptversammlung 2025 der Medios AG: Aktionäre stimmen sämtlichen Beschlussvorschlägen zu
Berlin, 27. Mai 2025 – Die Aktionäre von Medios, ein führender Anbieter von Specialty Pharma in Europa, haben heute auf der ordentlichen Hauptversammlung 2025 allen Beschlussvorschlägen von Vorstand und Aufsichtsrat mit großer Mehrheit zuge......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2025
ILM1
LISTED
XETR
Shareholders approve all proposed resolutions
News Preview
Press release
Medios AG Annual General Meeting 2025: Shareholders approve all proposed resolutions
Berlin, May 27, 2025 – The shareholders of Medios, a leading provider of Specialty Pharma in Europe, today approved all resolutions proposed by the Executive Board and Supervisory Board at the 2025 Annual General Meeting with a large majority. In to......
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
ATNM
LISTED
XASE
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM) and reminds investors of the May 26, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2025
FYB
LISTED
XETR
Formycon und Fresenius Kabi geben Markteinführung des Ustekinumab-Biosimilars FYB202/Otulfi™ in Kanada bekannt
News Preview
Pressemitteilung // 27. Mai 2025
Formycon und Fresenius Kabi geben Markteinführung des Ustekinumab-Biosimilars FYB202/OtulfiTM in Kanada bekannt
FYB202/OtulfiTM1 ab sofort in Kanada für subkutane und intravenöse Anwendung verfügbar
Der Launch in Kanada stärkt die Marktpräsenz von OtulfiTM über die USA und Europa hinaus und verbessert den Zugan......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2025
FYB
LISTED
XETR
Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada
News Preview
Press Release // May 27, 2025
Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar, in Canada
FYB202/Otulfi™ is now commercially available in Canada in both subcutaneous and intravenous formulations
Launch expands market presence beyond the U.S. and Europe, offering broader treatment ......
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
INDV
LISTED
NASDAQ
Indivior Announces Patrick Barry as Chief Commercial Officer
News Preview
Seasoned commercial executive with more than 30 years of pharmaceutical experience
RICHMOND, Va., May 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the appointment of Patrick Barry as Chief Commercial Officer, effective June 2. In this role, Barry will lead the company's commercial growth strategy, execution, and operat...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
BLUE
LISTED
NASDAQ
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
News Preview
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”) today reminds all stockholders to promptly tender their shares into the tender offer by Carlyle and SK Capital to purchase all outstanding shares of bluebird common stock by 11:59 p.m. Eastern on May 29, 2025. Stockholders that hold shares of bluebird through a broker or other nominee...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025 at 10.40 am CT.
Any changes to this event and links to the live webcast (where availab...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2025
SN
LISTED
LSE
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA)....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2025
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the 46th Goldman Sachs Annual Global Healthcare Conference
News Preview
Media ReleaseCOPENHAGEN, Denmark; May 27, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the 46th Goldman Sachs Annual Global Healthcare Conference in Miami, Florida at 8:00 AM EDT (2:00 PM CEST) on June 9, 2025. A webcast of the fireside chat will be available on...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
DFTX
LISTED
NASDAQ
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L. Roberts as its Chief Financial Officer (CFO), effective June 2, 2025. In her new role, Ms. Roberts will join Min...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
TEM
LISTED
NASDAQ
New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis
News Preview
Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), and a leader in clinical genomic testing, today announced the publication of a study in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG). The study reveals the potentially transformative impact of Ambry Genetics...
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
OGI
LISTED
NASDAQ
Organigram Global Announces CEO Succession Plan
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada’s #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company’s current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as C...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
HIK
LISTED
LSE
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
News Preview
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. today announced that the U.S. Food and Drug Adm...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
HIK
LISTED
LSE
Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
News Preview
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. today announced that the U.S. Food and Drug Adm...
Themefolio
Profiler
Peergroup
© BusinessWire
26.05.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
IBAB
LISTED
EURONEXT
Iba – Acquisition of Own Shares
News Preview
Immediate Release – May 26th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition resumes patient inclusion in its Phase 1b/2a clinical study
News Preview
STOCKHOLM, SWEDEN – May 26, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has resumed the inclusion of patients to the clinical phase 1b/2a trial evaluating the drug candidate golexanolone in PBC patients. In March, Umecrine Cognition announced that the study had been halted d...
Themefolio
Profiler
Peergroup
© BusinessWire
23.05.2025
ATNM
LISTED
XASE
ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024. Actinium describes itself as a “late-stage biopharmaceutical company that develops targeted radiothe...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2025
GN
LISTED
CPH
Major shareholder notification – BlackRock, Inc.
News Preview
GN Store Nord A/S hereby announces that on May 22, 2025, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on May 21, 2025, BlackRock, Inc. increased its aggregate direct and indirect holding of shares and financial instruments, cf. Section 38 and Sections 39(...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2025
TIL
LISTED
NASDAQ
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
News Preview
DALLAS and SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil") and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, “ImmuneOnco”), today announced that they will jointly host an investor and research analyst breakfast in Chicago, Illinois on Saturday, May 31, 2025 at 8:00 to 9:30 am CT adjacent to...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2025
EUZ
LISTED
XETR
Eckert & Ziegler zum zweiten Mal mit „Best Managed Companies Award“ ausgezeichnet
News Preview
Berlin, 23. Mai 2025. Die Eckert & Ziegler SE (ISIN DE0005659700) ist erneut Preisträger des „Best Managed Companies Award“. Deloitte Private, UBS und die Frankfurter Allgemeine Zeitung zeichnen gemeinsam mit dem Bundesverband der Deutschen Industrie (BDI) hervorragend geführte Unternehmen aus dem deutschen Mittelstand aus. Eckert & Ziegler......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.05.2025
EUZ
LISTED
XETR
Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
News Preview
Berlin, May 23, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has once again been honored with the “Best Managed Companies Award”. The award, presented by Deloitte Private, UBS, the Frankfurter Allgemeine Zeitung and the Federation of German Industries (BDI), recognize excellently managed medium-sized companies throughout Germany. Eckert & ......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2025
ORNBV
LISTED
HEL
Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market
News Preview
ORION CORPORATION PRESS RELEASE 23 MAY 2025 at 12.40 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025
News Preview
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
